Measurement of the glycaemic index (GI) of two enteral nutrition formulations in healthy subjects
Not Applicable
- Conditions
- healthy volunteers
- Registration Number
- DRKS00006185
- Lead Sponsor
- Fresenius Kabi Deutschland GmbH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 12
Inclusion Criteria
Healthy subjects who give informed consent to participate in the study
Exclusion Criteria
- Aged <18 or>60 years
- Pregnant or lactating
- Body mass index (BMI) 30kg/m2 or above
- History of diabetes mellitus or fasting blood glucose value >6.1mmol/L
- Any known food allergy or intolerance
- Medical condition(s) or medication(s) known to affect glucose regulation or appetite and/or influence digestion and absorption of nutrients
- Use of steroids, protease inhibitors, amphetamines or antipsychotics
- Use of medications known to affect glucose tolerance (excluding oral contraceptives)
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method